Quick swab test could prevent newborn sepsis

NCT ID NCT03371056

Completed Diagnosis Sponsor: Assistance Publique - Hôpitaux de Paris Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tested a new rapid test (InSPIRe kit) that uses a simple vaginal swab to detect bacteria and infection markers in pregnant women. The goal is to quickly identify women who might pass harmful bacteria to their babies during birth, so doctors can prevent newborn infections. Over 2,500 pregnant women took part, and the test was compared to standard lab methods.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: InSPIRe kit (rapid diagnostic test)
What this could lead to: If successful, this test could help doctors quickly identify pregnant women carrying harmful bacteria, allowing early treatment to prevent infections in newborns.
What could go wrong: This is a completed study validating a diagnostic tool, not a treatment. The test may not be widely adopted or may not improve outcomes in real-world settings.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for NEONATAL INFECTION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

NEONATAL INFECTION

Contacts and locations

Locations

Hopital Bichat

Paris, 75018, France
Hopital Louis Mourier

Colombes, 92700, France
Hôpital Cochin

Paris, 75014, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.